140 related articles for article (PubMed ID: 10479474)
1. Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).
Zara GP; Cavalli R; Fundarò A; Bargoni A; Caputo O; Gasco MR
Pharmacol Res; 1999 Sep; 40(3):281-6. PubMed ID: 10479474
[TBL] [Abstract][Full Text] [Related]
2. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.
Fundarò A; Cavalli R; Bargoni A; Vighetto D; Zara GP; Gasco MR
Pharmacol Res; 2000 Oct; 42(4):337-43. PubMed ID: 10987994
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats.
Zara GP; Bargoni A; Cavalli R; Fundarò A; Vighetto D; Gasco MR
J Pharm Sci; 2002 May; 91(5):1324-33. PubMed ID: 11977108
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
5. Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues.
Zara GP; Cavalli R; Bargoni A; Fundarò A; Vighetto D; Gasco MR
J Drug Target; 2002 Jun; 10(4):327-35. PubMed ID: 12164381
[TBL] [Abstract][Full Text] [Related]
6. Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model.
Arnold RD; Mager DE; Slack JE; Straubinger RM
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8856-65. PubMed ID: 16361575
[TBL] [Abstract][Full Text] [Related]
7. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q
Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).
Parr MJ; Masin D; Cullis PR; Bally MB
J Pharmacol Exp Ther; 1997 Mar; 280(3):1319-27. PubMed ID: 9067319
[TBL] [Abstract][Full Text] [Related]
9. Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues.
Patel KJ; Trédan O; Tannock IF
Cancer Chemother Pharmacol; 2013 Jul; 72(1):127-38. PubMed ID: 23680920
[TBL] [Abstract][Full Text] [Related]
10. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
Ishida T; Atobe K; Wang X; Kiwada H
J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
[TBL] [Abstract][Full Text] [Related]
11. Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase.
Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Yang H
J Pharm Pharmacol; 2008 Dec; 60(12):1651-7. PubMed ID: 19000370
[TBL] [Abstract][Full Text] [Related]
12. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
Harasym TO; Cullis PR; Bally MB
Cancer Chemother Pharmacol; 1997; 40(4):309-17. PubMed ID: 9225948
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting.
Bragagni M; Mennini N; Ghelardini C; Mura P
J Pharm Pharm Sci; 2012; 15(1):184-96. PubMed ID: 22365096
[TBL] [Abstract][Full Text] [Related]
14. [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice].
Xu XY; Zhou JP; Li L; Zhang Y; Huo MR; Wang X; Lü L
Yao Xue Xue Bao; 2008 Jul; 43(7):743-8. PubMed ID: 18819480
[TBL] [Abstract][Full Text] [Related]
15. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
[TBL] [Abstract][Full Text] [Related]
16. An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation.
Gokhale PC; Radhakrishnan B; Husain SR; Abernethy DR; Sacher R; Dritschilo A; Rahman A
Br J Cancer; 1996 Jul; 74(1):43-8. PubMed ID: 8679456
[TBL] [Abstract][Full Text] [Related]
17. [Preparation of the EPC and HEPC sterically stabilized doxorubicin liposomes and further studies on pharmacokinetics in rats].
Yu M; Wang Y; Shu G; Zhu Z; Fang S; Wang L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):597-9. PubMed ID: 18693438
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C
J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin.
Tian J; Pang X; Yu K; Liu L; Zhou J
Pharmazie; 2008 Aug; 63(8):593-7. PubMed ID: 18771008
[TBL] [Abstract][Full Text] [Related]
20. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
